More Confirmation Stents Overused

Merrill Goozner

First posted 7/6/11, 2011 on GoozNews

Another day, another study showing that invasive cardiologists overuse angioplasty and insert unneeded stents in patients without acute symptoms of coronary artery disease. The latest study, which appeared in today’s Journal of the American Medical Association, deemed 15 percent of the 600,000 angioplasties done every year are either inappropriate or their necessity is uncertain.

Continue reading “More Confirmation Stents Overused”

More Confirmation Stents Overused

Merrill Goozner

First posted 7/6/11 on GoozNews

Another day, another study showing that invasive cardiologists overuse angioplasty and insert unneeded stents in patients without acute symptoms of coronary artery disease. The latest study, which appeared in today’s Journal of the American Medical Association, deemed 15 percent of the 600,000 angioplasties done every year are either inappropriate or their necessity is uncertain.

Since the COURAGE trial results were released in 2007, cardiologists have known that drug intervention (primarily statins) works just as well or better than angioplasty in patients with stable coronary artery disease (cost: $1,000 a year or less if generics are used compared to $20,000 for the stent operation). A study that came out two months ago showed there had been no change in cariology practice in the wake of the COURAGE trial. This latest study confirms that invasive cardiology is largely an evidence-free zone where the self-interest of the surgeons and the hospitals trumps the needs of patients, who have no clue as to what’s going on. “Thank God the doctor did that operation. I could have died tomorrow.”

Continue reading “More Confirmation Stents Overused”

The COURAGE Trial Aftermath – No Change in Practice

Merrill Goozner

First published 5/11/11 on Gooz News

The COURAGE trial, announced with great fanfare in 2007, showed giving drugs and counseling to people with stable coronary artery disease was just as effective in reducing heart attacks, strokes and early death as subjecting patients to balloon angioplasty and inserting stents, which are far more expensive procedures than giving drugs. And how did the nation’s cardiologists respond to this startling news, which, if you were a cardiologist, you had to be living in Abbottabad to miss? A study in today’s Journal of the American Medical Association showed (from MedPage Today):

Continue reading “The COURAGE Trial Aftermath – No Change in Practice”